Group 1 - The Shandong provincial government is enhancing cooperation with multinational companies to support high-level opening-up, showcasing successful foreign investment efforts [1][4] - The AstraZeneca inhalation aerosol production base in Shandong is a key project, with total investment reaching $750 million, reflecting the province's commitment to attracting foreign investment [2][3] - The project aims to produce 54 million respiratory drugs annually and achieve "zero carbon factory" goals, with the first phase expected to be operational by 2028 [3] Group 2 - Shandong has over 19,000 foreign-funded enterprises, including 236 Fortune 500 companies, indicating a robust foreign investment landscape [3] - Recent surveys show strong intentions from foreign companies to maintain or increase investments in China, highlighting the province's attractiveness as an investment destination [3] - Shandong's policies aim to create a market-oriented, law-based, and international business environment to further attract multinational companies [4] Group 3 - Companies like Eddys and Hexagon have significantly increased their investments and production capabilities in Shandong, demonstrating the province's favorable business environment [5][6] - Hexagon's revenue in the Greater China region has grown approximately 55 times from 2000 to 2024, showcasing the success of its operations in Shandong [6][7] - The collaboration between Shandong and multinational companies is mutually beneficial, contributing advanced technology and management experience to the local economy [7][8] Group 4 - Shandong is positioned as a key area for international cooperation, leveraging platforms like free trade zones to enhance its business environment [8]
山东为何成为跨国公司布局中国的“引力场”